CLINICAL_TRIALS
withdrawal
· 2024-09-23
Clinical Trial Update: Improving Function, Quality of Life, Glycemia in Diabetics With Dementia [Phase 4]
Summary
A Phase 4 trial investigating whether improving function, quality of life, and glycemic control in people with diabetes and dementia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Nebraska | Conditions: Diabetes Mellitus, Alzheimer's Disease | Phase 4 | Status: WITHDRAWN